BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4283774)

  • 1. A new approach for refractory oedema--pharmacological paracentesis.
    Sonwalkar AV; Wechalekar MD; Wechalekar DK; Waikar SM; Bhala BB
    J Assoc Physicians India; 1973 Jul; 21(7):585-8. PubMed ID: 4283774
    [No Abstract]   [Full Text] [Related]  

  • 2. [Refractory hepatic cirrosis and the ineffectiveness of diuretics in ascites and edema].
    Inoue J; Mori Y; Kawamura T
    Naika; 1969 Nov; 24(5):834-9. PubMed ID: 4902224
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of a new diuretic agent (metolazone) in patients with edema and ascites.
    Lowenthal DT; Shear L
    Arch Intern Med; 1973 Jul; 132(1):38-41. PubMed ID: 4716425
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical program of therapy for ascitic edema in liver disease].
    Pupita F; Ansuini R; Frausini G
    Clin Ter; 1982 Jan; 100(2):115-33. PubMed ID: 7186421
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical experience with furosemide.
    Herrmann GR; Ghiselli RG
    South Med J; 1968 Oct; 61(10):1083-8. PubMed ID: 5746300
    [No Abstract]   [Full Text] [Related]  

  • 6. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
    Cho HS; Park GT; Kim YH; Shim SG; Kim JB; Lee OY; Choi HS; Hahm JS; Lee MH
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):324-31. PubMed ID: 14695699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined ascitic-fluid and furosemide infusion in the management of ascites.
    Eknoyan G; Martinez-Maldonado M; Yium JJ; Suki WN
    N Engl J Med; 1970 Mar; 282(13):713-7. PubMed ID: 5416204
    [No Abstract]   [Full Text] [Related]  

  • 8. [Controlled clinical trial of the association of furosemide and triamterene].
    Azzi E; Perraro F
    Clin Ter; 1971 Mar; 56(6):501-22. PubMed ID: 5131091
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined ascitic--fluid and furosemide infusion: a therapeutic option for massive diuretic-resistant ascites and severe oliguria of hepatic cirrhosis.
    Onuigbo MA; Ozoh JO; Nusiem CA; Onyeagocha AC; Nwaneri O; Offodile AA; Ijoma CK
    Cent Afr J Med; 1991 Aug; 37(8):244-7. PubMed ID: 1807797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experience in the treatment of water-salt retentions in cirrhosis by the antialdosterone 11614 R.P].
    Boivin P; Fauvert R
    Rev Int Hepatol; 1969; 19(4):241-51. PubMed ID: 5404532
    [No Abstract]   [Full Text] [Related]  

  • 11. Ascites: diagnosis and management.
    Hou W; Sanyal AJ
    Med Clin North Am; 2009 Jul; 93(4):801-17, vii. PubMed ID: 19577115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intensive saluresis in the treatment of refractory edema due to chronic liver disease].
    Pupita F; Bargnesi P
    Clin Ter; 1972 Mar; 60(5):415-28. PubMed ID: 5038774
    [No Abstract]   [Full Text] [Related]  

  • 13. [The salidiuretic interaction of angiotensin II and furosemide in ascitogenic hepatic cirrhosis].
    Ventura E; Zeneroli ML
    Folia Endocrinol; 1969 Dec; 22(4):345-53. PubMed ID: 4329093
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hydrothorax in absence of ascites: an unusual complication of hepatic cirrhosis with portal hypertension].
    Rombolà F; Spinoso A; Ranieri FS; Bertuccio A; Del Giudice AC; Bertuccio SN
    Clin Ter; 2005; 156(4):179-81. PubMed ID: 16342519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Water and sodium metabolism in non-compensated hepatic cirrhosis: therapeutic indications according to the Arroyo classification].
    Cavatorta F; Queirolo C; Brignole M; Zangani F
    Clin Ter; 1980 Jan; 92(2):143-53. PubMed ID: 7389274
    [No Abstract]   [Full Text] [Related]  

  • 16. [Furosemide-amiloride combination in the treatment of ascitic-edema in patients with hepatic cirrhosis].
    Uribe M; Rojas S; Casián C; Sierra JG; Moreno J; Lewis H; Guevara L
    Rev Gastroenterol Mex; 1980; 45(2):63-8. PubMed ID: 7403764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology and management of portal hypertension. 2: Cirrhotic ascites.
    Stanley AJ; Bouchier IA; Hayes PC
    Br J Hosp Med; 1997 Jul 9-Aug 19; 58(2-3):74-8. PubMed ID: 9349370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Furosemide-induced natriuresis as a test to identify cirrhotic patients with refractory ascites.
    Spahr L; Villeneuve JP; Tran HK; Pomier-Layrargues G
    Hepatology; 2001 Jan; 33(1):28-31. PubMed ID: 11124817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of ascites in the patient with portal hypertension with emphasis on spontaneous bacterial peritonitis.
    Navasa M; Rodés J
    Semin Gastrointest Dis; 1997 Oct; 8(4):200-9. PubMed ID: 9360284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generalized burning paresthesia due to intravenous furosemide.
    Materson BJ
    J Fla Med Assoc; 1971 Jun; 58(6):34-5. PubMed ID: 5088026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.